Skip to main content
Pharmicell Co.,Ltd. logo

Pharmicell Co.,Ltd. — Investor Relations & Filings

Ticker · 005690 ISIN · KR7005690003 KO Manufacturing
Open in API
Filings indexed 275 across all filing types
Latest filing 2020-03-31 Major Shareholding Noti…
Country KR South Korea
Listing KO 005690

About Pharmicell Co.,Ltd.

https://www.pharmicell.com/eng/

Pharmicell Co., Ltd. is a biopharmaceutical company specializing in stem cell technology and advanced bio-based materials. The company is a pioneer in regenerative medicine, having developed Hearticellgram-AMI, the world's first approved stem cell therapy for acute myocardial infarction. Its core business includes the development of stem cell therapeutics, a stem cell banking service for adult and cord blood cells, and a line of cosmetics based on stem cell culture media. A significant division focuses on fine chemicals, manufacturing and supplying critical raw materials for the pharmaceutical industry, such as nucleosides, mPEGs, and oligonucleotides for gene therapies. The company also produces eco-friendly flame retardants for industrial use.

Recent filings

Filing Released Lang Actions
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Major Shareholding Notification' (최대주주등소유주식변동신고서) filed by Pharmicell. It details changes in share ownership by the largest shareholder and related parties, including specific tables for individual changes and total ownership status. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership thresholds and changes in holdings by major stakeholders.
2020-03-31 Korean
사업보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Pharmicell Co., Ltd. for the fiscal year ending December 31, 2019. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. While it contains financial data, it is a formal audit report rather than a standalone 'Annual Report' (10-K) or 'Interim Report' (IR), and it is not an announcement of a report (RPA). Based on the provided definitions, 'Audit Report / Information' (AR) is the most accurate classification. FY 2019
2020-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment or dismissal of an outside director. This falls under the category of changes in the company's board of directors or senior management.
2020-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, election of directors, and other resolutions passed during the meeting. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2020-03-25 Korean
투자판단관련주요경영사항((특허권 취득))
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Pharmicell regarding the acquisition of a patent ('특허권 취득'). It follows the standard format for 'Major Management Matters' (주요경영사항) in the Korean stock market (DART system). Since it does not fit into specific categories like financial reports, board changes, or dividends, and is a formal regulatory disclosure of a material event, it falls under the general regulatory filing category.
2020-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It provides the audit opinion, financial statements, and auditor information for the fiscal year 2019. While it contains financial data, it is specifically a standalone audit report filing rather than a full Annual Report (10-K) or a simple announcement of report publication (RPA). Therefore, it fits the 'Audit Report / Information' (AR) category. FY 2019
2020-03-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.